Pro Share Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,219 shares of HRMY stock, worth $347,752. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,219

Previous 11,812 13.49%

Holding current value

$347,752

Previous $373,000 24.66%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$26.76 - $38.05 $42,628 - $60,613	-1,593 Reduced 13.49%	10,219 $281,000
Q2 2025 Aug 07, 2025	BUY	$27.94 - $35.91 $6,901 - $8,869	247 Added 2.14%	11,812 $373,000
Q1 2025 May 08, 2025	SELL	$32.18 - $40.46 $84,472 - $106,207	-2,625 Reduced 18.5%	11,565 $383,000
Q4 2024 Feb 13, 2025	BUY	$31.86 - $41.49 $144,453 - $188,115	4,534 Added 46.96%	14,190 $488,000
Q3 2024 Nov 13, 2024	BUY	$30.0 - $39.95 $35,910 - $47,820	1,197 Added 14.15%	9,656 $385,000

Q2 2024 Aug 13, 2024	SELL	$28.81 - $33.01 $58,455 - $66,977	-2,029 Reduced 19.35%	8,459 $255,000
Q1 2024 May 08, 2024	BUY	$29.93 - $35.06 $20,472 - $23,981	684 Added 6.98%	10,488 $352,000
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $16,320 - $28,713	850 Added 9.49%	9,804 $316,000
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $63 - $78	2 Added 0.02%	8,954 $293,000
Q2 2023 Aug 10, 2023	BUY	$30.5 - $37.4 $28,182 - $34,557	924 Added 11.51%	8,952 $315,000
Q1 2023 May 11, 2023	SELL	$30.8 - $53.92 $34,372 - $60,174	-1,116 Reduced 12.2%	8,028 $262,000
Q4 2022 Feb 02, 2023	BUY	$45.4 - $60.91 $21,383 - $28,688	471 Added 5.43%	9,144 $503,000
Q3 2022 Nov 04, 2022	BUY	$42.06 - $55.45 $19,642 - $25,895	467 Added 5.69%	8,673 $384,000
Q2 2022 Aug 01, 2022	SELL	$33.54 - $52.15 $100,284 - $155,928	-2,990 Reduced 26.71%	8,206 $400,000
Q1 2022 May 10, 2022	SELL	$33.14 - $51.13 $91,864 - $141,732	-2,772 Reduced 19.85%	11,196 $544,000
Q4 2021 Feb 08, 2022	BUY	$34.09 - $43.91 $476,169 - $613,334	13,968 New	13,968 $595,000

Others Institutions Holding HRMY

# of Institutions

317

Shares Held

43.9M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History